Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H8N2 |
| Molecular Weight | 108.1411 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NNC1=CC=CC=C1
InChI
InChIKey=HKOOXMFOFWEVGF-UHFFFAOYSA-N
InChI=1S/C6H8N2/c7-8-6-4-2-1-3-5-6/h1-5,8H,7H2
| Molecular Formula | C6H8N2 |
| Molecular Weight | 108.1411 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/19277535Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/26717206 | https://www.ncbi.nlm.nih.gov/pubmed/6732840
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19277535
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/26717206 | https://www.ncbi.nlm.nih.gov/pubmed/6732840
Phenylhydrazine (also known as the hydrazinobenzene) is an industrial substance suspect of carcinogenic potential for humans. Phenylhydrazine was the first hydrazine derivative characterized, reported by Emil Fischer in 1875. Phenyl-hydrazine is used to prepare indoles via the Fischer Indole Synthesis, which are intermediates in the synthesis of various dyes and pharmaceuticals. This molecule is also used to induce acute hemolytic anemia in animal models. Exposure to phenylhydrazine may cause contact dermatitis, hemolytic anemia, and liver damage.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL4685 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26717206 |
230.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Kinetics and mechanism of the nucleophilic displacement reactions of chloroacetanilide herbicides: investigation of alpha-substituent effects. | 2004-05-19 |
|
| Erythroid cells in immunoregulation: characterization of a novel suppressor factor. | 2004-05-15 |
|
| Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems. | 2004-05-06 |
|
| Matrix-assisted laser desorption/ionization tandem mass spectrometry and post-source decay fragmentation study of phenylhydrazones of N-linked oligosaccharides from ovalbumin. | 2004-05 |
|
| Effect of alkyl-beta,d-glucopyranosides on hypertonic haemolysis of erythrocytes. | 2004-05 |
|
| Synthesis and characterization of zinc sensors based on a monosubstituted fluorescein platform. | 2004-04-19 |
|
| A sulfido-bridged diiron(II) compound and its reactions with nitrogenase-relevant substrates. | 2004-04-14 |
|
| S-stereoselective piperazine-2-tert-butylcarboxamide hydrolase from Pseudomonas azotoformans IAM 1603 is a novel L-amino acid amidase. | 2004-04 |
|
| Interaction of TRPC2 and TRPC6 in erythropoietin modulation of calcium influx. | 2004-03-12 |
|
| Fast-flow EPR spectroscopic observation of the isoniazid, iproniazid, and phenylhydrazine hydrazyl radicals. | 2004-02 |
|
| Gestational diabetes affects platelet behaviour through modified oxidative radical metabolism. | 2004-01 |
|
| Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat. | 2003-11-28 |
|
| [Activity of key enzymes of heme metabolism and cytochrome P-450 content in the rat liver in experimental rhabdomyolysis and hemolytic anemia]. | 2003-10-28 |
|
| Profiling of N-linked oligosaccharides using phenylhydrazine derivatization and mass spectrometry. | 2003-10-17 |
|
| Formation of meso, N-diphenylprotoporphyrin IX by an aerobic reaction of phenylhydrazine with oxyhemoglobins. | 2003-10 |
|
| An NMR and X-ray study of the structure of the azo coupling product of 4-dimethylaminopent-3-en-2-one and benzenediazonium-tetrafluoroborate. | 2003-09-21 |
|
| Tandem hydroformylation/Fischer indole synthesis: a novel and convenient approach to indoles from olefins. | 2003-09-04 |
|
| Structure of the phenylhydrazine adduct of the quinohemoprotein amine dehydrogenase from Paracoccus denitrificans at 1.7 A resolution. | 2003-09 |
|
| Amperometric and spectrophotometric determination of carbaryl in natural waters and commercial formulations. | 2003-09 |
|
| Labelling saccharides with phenylhydrazine for electrospray and matrix-assisted laser desorption-ionization mass spectrometry. | 2003-08-05 |
|
| Optosensing behavior of the first Ru(II)-compound of di-2-pyridylketone-p-nitrophenylhydrazone (dpknph), [Ru(bpy)2(dpknph)]Cl2. | 2003-07 |
|
| Synthesis of new chiral 2,2'-bipyridine ligands and their application in copper-catalyzed asymmetric allylic oxidation and cyclopropanation. | 2003-06-13 |
|
| Nucleophilic substitution reactions of alpha-chloroacetanilides with benzylamines in dimethyl sulfoxide. | 2003-06-07 |
|
| Synthesis and characterization of model compounds of the lysine tyrosyl quinone cofactor of lysyl oxidase. | 2003-05-21 |
|
| Pharmaco-economical analysis of the treatment with antibiotics in a surgery department. | 2003-05 |
|
| Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part I). | 2003-04-23 |
|
| Hematopoietic capacity of connexin43 wild-type and knock-out fetal liver cells not different on wild-type stroma. | 2003-04-15 |
|
| Inactivation of bovine plasma amine oxidase by 4-aryloxy-2-butynamines and related analogs. | 2003-04-11 |
|
| Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine. | 2003-04-11 |
|
| Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part 2). | 2003-04 |
|
| Isolation of 4-chloro-3-formyl-2-(2-hydroxyethene-1-yl) quinolines by Vilsmeier Haack reaction on quinaldines: Construction of diazepino quinoline heterocycles and their antimicrobial and cytogenetic studies. | 2003-03 |
|
| Saturation transfer in human red blood cells with normal and unstable hemoglobin. | 2003-02 |
|
| Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine. | 2003-01 |
|
| The fate of dolichol in rat cells and tissues. | 2003 |
|
| Haemoglobin biosynthesis site in rabbit embryo erythroid cells. | 2003 |
|
| [Metabolism of heme and hemeproteins and some indices of the antioxidant system in rat erythrocytes and tissues under anemia caused by phenylhydrazine]. | 2003 |
|
| The microrheological changes in the course of erythrocyte senescence after phenylhydrazine injection. | 2003 |
|
| The influence of Sacoglottis gabonensis stem bark extract and its isolate bergenin, Nigerian alcoholic beverage additives, on the metabolic and haematological side effects of 2,4-dinitrophenyl hydrazine-induced tissue damage. | 2002-12 |
|
| Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. | 2002-12 |
|
| Analysis of heme oxygenase isomers in rat. | 2002-12 |
|
| [The immunometaboic effects of benfotiamine and riboxine on hemolytic anemia]. | 2002-11-27 |
|
| Mutation of alphaPhe55 of methylamine dehydrogenase alters the reorganization energy and electronic coupling for its electron transfer reaction with amicyanin. | 2002-11-26 |
|
| Stability of agaritine - a natural toxicant of Agaricus mushrooms. | 2002-11 |
|
| Synthesis, structural characterization and antimicrobial studies of hydrazone derivatives of 3-hydroxyimino-5-methyl-2-hexanone. | 2002-10-31 |
|
| Revisiting the Ullmann-ether reaction: a concise and amenable synthesis of novel dibenzoxepino[4,5-d]pyrazoles by intramolecular etheration of 4,5-(o,o'-halohydroxy)arylpyrazoles. | 2002-10-18 |
|
| C-C bond formation via C-H bond activation: synthesis of the core of teleocidin B4. | 2002-10-09 |
|
| Phenylhydrazide as an enzyme-labile protecting group in peptide synthesis. | 2002-10-04 |
|
| The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. | 2002-10 |
|
| Influence of storage and household processing on the agaritine content of the cultivated Agaricus mushroom. | 2002-09 |
|
| The role of thyroid hormone on phenylhydrazine hydrochloride mediated inhibitory effects on blood acetylcholinesterase: an in vivo and in vitro study. | 2002 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10753835
In experimental mice, phenylhydrazine (PHZ; 60 mg/kg body weight; Sigma Chem, St. Louis, MO) was injected intraperitoneally for 2 consecutive days.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6732840
Blood was drawn from healthy donors using 3.13% sodium citrate as the anticoagulant (1: 5, v/v). Cells were isolated using isoosmotic phosphate-buffered saline (PBS, pH 7,4), microcrystalline cellulose and Lu-cellulose (1: 1, w/w) as described by Beutler et al. Red blood cells were suspended in PBS and preincubated in glass test-tubes in a shaking water bath for 1 hr at 37C, after which haematocrit was adjusted to 2.5% by adding PBS. Samples containing hemoglobin were adjusted to 8 mg/ml hemoglobin in PBS, i.e. a concentration comparable to that used in experiments with red cells. Varying amounts of phenylhydrazine, ranging from 0.5 to 50 mM were added to the red blood cell or hemoglobin samples. Then 3 ml of each sample was aliquoted into 10 ml headspace vials, and the vials were immediately sealed with special air-tight rubber septums. Headspaces were flushed with hydrocarbon-free synthetic air for 2 min in order to replace laboratory air containing small amounts of hydrocarbons. The sealed samples were then incubated in a shaking water bath at 37C. After certain periods, 1 ml of the gas phase was drawn with a gas-tight syringe and injected into the gas chromatograph.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:56:32 GMT 2025
by
admin
on
Mon Mar 31 18:56:32 GMT 2025
|
| Record UNII |
064F424C9K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
202-873-5
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
100-63-0
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
8167
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID8021147
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
C030299
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
27924
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
PHENYLHYDRAZINE
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
1117
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
300000053580
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
m8674
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
7516
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY | |||
|
064F424C9K
Created by
admin on Mon Mar 31 18:56:32 GMT 2025 , Edited by admin on Mon Mar 31 18:56:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|